GeneCraft Raises KRW 10 Billion in Series A for Advanced Lung Cancer Gene Therapy
Korean biotech company GeneCraft has successfully closed a Series A funding round, raising KRW 10 billion. Key investors include Seoul Techno...
Korean biotech company GeneCraft has successfully closed a Series A funding round, raising KRW 10 billion. Key investors include Seoul Techno...